Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

Immunization of T-cell deficient mice against polyomavirus infection using viral pseudocapsids or temperature sensitive mutants.

Heidari S, Vlastos A, Ramqvist T, Clark B, Griffin BE, Garcia MI, Perez M, Amati P, Dalianis T.

Vaccine. 2002 Feb 22;20(11-12):1571-8.

PMID:
11858864
[PubMed - indexed for MEDLINE]
2.

VP1 pseudocapsids, but not a glutathione-S-transferase VP1 fusion protein, prevent polyomavirus infection in a T-cell immune deficient experimental mouse model.

Vlastos A, Andreasson K, Tegerstedt K, Holländerová D, Heidari S, Forstová J, Ramqvist T, Dalianis T.

J Med Virol. 2003 Jun;70(2):293-300.

PMID:
12696121
[PubMed - indexed for MEDLINE]
3.

Genetic immunization is augmented by murine polyomavirus VP1 pseudocapsids.

Rollman E, Ramqvist T, Zuber B, Tegerstedt K, Kjerrström Zuber A, Klingström J, Eriksson L, Ljungberg K, Hinkula J, Wahren B, Dalianis T.

Vaccine. 2003 Jun 2;21(19-20):2263-7.

PMID:
12744856
[PubMed - indexed for MEDLINE]
4.
5.

Adult X-linked immunodeficiency (XID) mice, IGM-/- single knockout and IGM-/- CD8-/- double knockout mice do not clear polyomavirus infection.

Berke Z, Mellin H, Heidari S, Wen T, Berglöf A, Klein G, Dalianis T.

In Vivo. 1998 Mar-Apr;12(2):143-8.

PMID:
9627794
[PubMed - indexed for MEDLINE]
6.

Polyomavirus persists in CD4/8 double-knockout, but not in CD4 or CD8 single-knockout mice.

Berke Z, Wen T, Jin S, Klein G, Dalianis T.

Virology. 1995 Sep 10;212(1):268-71.

PMID:
7676644
[PubMed - indexed for MEDLINE]
Free Article
7.

Murine polyomavirus-VP1 virus-like particles immunize against some polyomavirus-induced tumours.

Franzén AV, Tegerstedt K, Holländerova D, Forstová J, Ramqvist T, Dalianis T.

In Vivo. 2005 Mar-Apr;19(2):323-6.

PMID:
15796193
[PubMed - indexed for MEDLINE]
Free Article
8.

An MHC class Ib-restricted CD8 T cell response confers antiviral immunity.

Swanson PA 2nd, Pack CD, Hadley A, Wang CR, Stroynowski I, Jensen PE, Lukacher AE.

J Exp Med. 2008 Jul 7;205(7):1647-57. doi: 10.1084/jem.20080570. Epub 2008 Jun 9.

PMID:
18541714
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Late priming and variability of epitope-specific CD8+ T cell responses during a persistent virus infection.

Kemball CC, Lee ED, Vezys V, Pearson TC, Larsen CP, Lukacher AE.

J Immunol. 2005 Jun 15;174(12):7950-60.

PMID:
15944301
[PubMed - indexed for MEDLINE]
Free Article
10.

Costimulation requirements for antiviral CD8+ T cells differ for acute and persistent phases of polyoma virus infection.

Kemball CC, Lee ED, Szomolanyi-Tsuda E, Pearson TC, Larsen CP, Lukacher AE.

J Immunol. 2006 Feb 1;176(3):1814-24.

PMID:
16424212
[PubMed - indexed for MEDLINE]
Free Article
11.

Cellular and humoral immune responses to chimeric EGFP-pseudocapsids derived from the mouse polyomavirus after their intranasal administration.

Fric J, Marek M, Hrusková V, Holán V, Forstová J.

Vaccine. 2008 Jun 19;26(26):3242-51. doi: 10.1016/j.vaccine.2008.04.006. Epub 2008 Apr 23.

PMID:
18468739
[PubMed - indexed for MEDLINE]
12.

Persistence and tissue distribution of DNA in normal and immunodeficient mice inoculated with polyomavirus VP1 pseudocapsid complexes or polyomavirus.

Heidari S, Krauzewicz N, Kalantari M, Vlastos A, Griffin BE, Dalianis T.

J Virol. 2000 Dec;74(24):11963-5.

PMID:
11090197
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Early virus-associated bystander events affect the fitness of the CD8 T cell response to persistent virus infection.

Andrews NP, Pack CD, Vezys V, Barber GN, Lukacher AE.

J Immunol. 2007 Jun 1;178(11):7267-75.

PMID:
17513776
[PubMed - indexed for MEDLINE]
Free Article
14.

Studies on polyomavirus persistence and polyomavirus-induced tumor development in relation to the immune system.

Berke Z, Dalianis T.

Adv Cancer Res. 2000;79:249-76. Review. No abstract available.

PMID:
10818683
[PubMed - indexed for MEDLINE]
15.

Generation of antiviral major histocompatibility complex class I-restricted T cells in the absence of CD8 coreceptors.

Andrews NP, Pack CD, Lukacher AE.

J Virol. 2008 May;82(10):4697-705. doi: 10.1128/JVI.02698-07. Epub 2008 Mar 12.

PMID:
18337581
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The temperature-sensitive mutants of Toxoplasma gondii and ocular toxoplasmosis.

Lu F, Huang S, Kasper LH.

Vaccine. 2009 Jan 22;27(4):573-80. doi: 10.1016/j.vaccine.2008.10.090. Epub 2008 Nov 19.

PMID:
19026704
[PubMed - indexed for MEDLINE]
17.

Beneficial therapeutic effects with different particulate structures of murine polyomavirus VP1-coat protein carrying self or non-self CD8 T cell epitopes against murine melanoma.

Brinkman M, Walter J, Grein S, Thies MJ, Schulz TW, Herrmann M, Reiser CO, Hess J.

Cancer Immunol Immunother. 2005 Jun;54(6):611-22. Epub 2005 Feb 1.

PMID:
15685447
[PubMed - indexed for MEDLINE]
18.

Segments of puumala hantavirus nucleocapsid protein inserted into chimeric polyomavirus-derived virus-like particles induce a strong immune response in mice.

Gedvilaite A, Zvirbliene A, Staniulis J, Sasnauskas K, Krüger DH, Ulrich R.

Viral Immunol. 2004;17(1):51-68.

PMID:
15018662
[PubMed - indexed for MEDLINE]
19.

T cell-independent and T cell-dependent immunoglobulin G responses to polyomavirus infection are impaired in complement receptor 2-deficient mice.

Szomolanyi-Tsuda E, Seedhom MO, Carroll MC, Garcea RL.

Virology. 2006 Aug 15;352(1):52-60. Epub 2006 Jun 2.

PMID:
16733062
[PubMed - indexed for MEDLINE]
Free Article
20.

[Expression of ts-3 mutant of polyoma virus in mouse cells (author's transl)].

Perreau J, Paulin D, Yaniv M.

Ann Microbiol (Paris). 1979 Jan;130 A(1):103-18. French.

PMID:
224746
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk